These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11709121

  • 21. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA, Blazquez AM, Fresnadillo MJ, Garcia Sanchez E, Garcia Sanchez JE, Trujillano Martin I.
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [Abstract] [Full Text] [Related]

  • 22. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Oct; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 23. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM, Johnson DM, Jones RN.
    J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
    Metan G, Zarakolu P, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2006 Dec; 40(1-2):23-8. PubMed ID: 16775953
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
    Weinstein MP.
    Diagn Microbiol Infect Dis; 1988 Dec; 11(4):195-200. PubMed ID: 3071448
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
    [Abstract] [Full Text] [Related]

  • 39. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

  • 40. In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.
    Kotilainen P, Pitkänen S, Siitonen A, Huovinen P, Hakanen AJ.
    Ann Clin Microbiol Antimicrob; 2005 Sep 05; 4():12. PubMed ID: 16143044
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.